Unveiling Intuitive Surgical Stock Essentials

By Scott Lee • Friday, November 07 15:24 • Permanent Link

Intuitive Surgical logged a 2.0% change during today's afternoon session, and is now trading at a price of $558.9 per share. The S&P 500 index moved -0.0%. ISRG's trading volume is 2,006,726 compared to the stock's average volume of 2,376,071.

Intuitive Surgical trades -5.74% away from its average analyst target price of $592.96 per share. The 29 analysts following the stock have set target prices ranging from $378.0 to $700.0, and on average have given Intuitive Surgical a rating of buy.

If you are considering an investment in ISRG, you'll want to know the following:

Intuitive Surgical's current price is 590.2% above its Graham number of $80.98, which implies that at its current valuation it does not offer a margin of safety
Intuitive Surgical has moved 2.1% over the last year, and the S&P 500 logged a change of 12.1%
Based on its trailing earnings per share of 7.56, Intuitive Surgical has a trailing 12 month Price to Earnings (P/E) ratio of 73.9 while the S&P 500 average is 29.3
ISRG has a forward P/E ratio of 71.1 based on its forward 12 month price to earnings (EPS) of $7.86 per share
Its Price to Book (P/B) ratio is 11.72 compared to its sector average of 3.19
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Based in Sunnyvale, the company has 15,638 full time employees and a market cap of $198.13 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.